Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anergis
Epalinges, Vaud, Switzerlandsunstone.eu ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Anergis has developed a proprietary ultra-fast immunotherapy platform using Contiguous Overlapping Peptides. Its lead product, AllerT for birch pollen allergy, reached Phase IIb and met its primary endpoint of reducing combined symptom and medication scores. Additional programs targeting house dust mite and ragweed allergies are in preclinical development. The company’s approach aims to achieve long-lasting desensitization with only two months of treatment, compared to years for conventional therapies.[1][2]
- Therapeutic areas
- Immunology
- Modalities
- Synthetic peptides (Contiguous Overlapping Peptides, COPs)Allergy vaccinesImmunotherapy[1][2][8]
- Industry
- Biotech
02
Partnerships
Mymetics SA/Mymetics Corporation – research collaboration on virosome-based delivery of COP vaccines for birch allergy.[6]Virometix AG – research collaboration on combining SVLP technology with Anergis’ house dust mite COP vaccine.[8]
Beyond the preview
Go deeper on Anergis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anergis.